CHLORURE DE SODIUM 0,9 % B. BRAUN, solution pour perfusion, OVX836 clinical trials

Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy, immunogenicity and safety of one dose of OVX836 influenza vaccine 480μg, after intramuscular administration in healthy subjects aged 18-59 years

This study is testing a new flu vaccine called OVX836 in healthy adults aged 18 to 59. We want to see how well it prevents the flu, if it's safe, and how the body reacts to it after just one shot. It's a careful study comparing the vaccine to a dummy treatment.